0001225208-17-000782.txt : 20170105 0001225208-17-000782.hdr.sgml : 20170105 20170105175025 ACCESSION NUMBER: 0001225208-17-000782 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170103 FILED AS OF DATE: 20170105 DATE AS OF CHANGE: 20170105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MACMILLAN STEPHEN P CENTRAL INDEX KEY: 0001239351 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 17512106 MAIL ADDRESS: STREET 1: 250 CAMPUS DRIVE CITY: MARLBOROUGH STATE: MA ZIP: 01752 4 1 doc4.xml X0306 4 2017-01-03 0000885725 BOSTON SCIENTIFIC CORP BSX 0001239351 MACMILLAN STEPHEN P 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 1 Deferred Stock Units 2017-01-03 4 A 0 771.0000 0.0000 A Common Stock 771.0000 16217.0000 D Stock Option (Right to Buy) 21.8800 2017-01-03 4 A 0 814.0000 0.0000 A 2027-01-03 Common Stock 814.0000 814.0000 D Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Reflects a value of $16,875 divided by the closing price of common stock on the date of grant. Deferred stock units were granted in lieu of 75% of the quarterly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reporting person received 25% of the cash compensation for the fourth quarter of 2016 in the form of an option to purchase a specified number of shares of common stock vesting in full upon the 2017 annual meeting of stockholders. /s/ Vance R. Brown, Attorney-in-fact 2017-01-05